A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-28
DOI
10.1038/s41467-021-20912-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation
- (2019) Mercedes Segovia et al. CANCER CELL
- Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
- (2019) Ivan Perrot et al. Cell Reports
- Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
- (2019) Jonathan Benzaquen et al. Biomedical Journal
- Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease
- (2019) Germain Homerin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tissue-Resident Memory T Cells in Cancer Immunosurveillance
- (2019) Simone L. Park et al. TRENDS IN IMMUNOLOGY
- Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
- (2019) Xian-Yang Li et al. Cancer Discovery
- Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation
- (2018) Francesco Di Virgilio et al. Frontiers in Pharmacology
- P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
- (2018) Chris N. J. Young et al. Frontiers in Chemistry
- Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance
- (2018) Zachary Schrank et al. Cancers
- ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
- (2018) SM Gilbert et al. ONCOGENE
- Ginsenosides Act As Positive Modulators of P2X4 Receptors
- (2018) Kshitija Dhuna et al. MOLECULAR PHARMACOLOGY
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- P2X7 receptor antagonists: a patent review (2010–2015)
- (2016) Jin-Hee Park et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
- (2016) Paul E. Hughes et al. TRENDS IN IMMUNOLOGY
- Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated Cancer
- (2015) P. Hofman et al. CANCER RESEARCH
- Immune Checkpoint Inhibitors in Melanoma Provide the Cornerstones for Curative Therapies
- (2015) Alexander M.M. Eggermont et al. SEMINARS IN ONCOLOGY
- Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
- (2015) Michael A. Postow et al. Journal for ImmunoTherapy of Cancer
- Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
- (2014) E. Adinolfi et al. CANCER RESEARCH
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
- (2014) Marina Fabbi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma
- (2014) Kate D. Sutherland et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural compounds with P2X7 receptor-modulating properties
- (2013) Wolfgang Fischer et al. Purinergic Signalling
- Regulation of P2X7-dependent inflammatory functions by P2X4 receptor in mouse macrophages
- (2012) Ayumi Kawano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration
- (2010) Annabelle Cesaro et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Extracellular NAD+shapes the Foxp3+regulatory T cell compartment through the ART2–P2X7 pathway
- (2010) Sandra Hubert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effect of adenosine 5′-triphosphate infusions on the nutritional status and survival of preterminal cancer patients
- (2009) Sandra Beijer et al. ANTI-CANCER DRUGS
- Atypical Protein Kinase C Is Required for Bronchioalveolar Stem Cell Expansion and Lung Tumorigenesis
- (2009) R. P. Regala et al. CANCER RESEARCH
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
- (2009) Michel DuPage et al. Nature Protocols
- Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
- (2008) Patrizia Pellegatti et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started